• About
  • What is VICH
  • Role of VICH
  • VICH Structure
  • VICH Process
  • What is the VICH Outreach Forum
• Guidelines
  • General
  • Biologicals
  • Pharmaceuticals
  • Pharmacovigilance
• Activities
  • Dates of next meetings
  • Dates of next Public conference
  • Public consultations
• Library
  • Press releases
  • VICH Statements
  • VICH Steering Committee Minutes
  • VICH Outreach Forum minutes
  • Concept Papers
  • Procedural Guidance
  • Organisational documents (Priorities, Strategy and charter)
  • Conference documents archive
  • Other Documents
• Training
  • General training material
  • Module 1 - General Topics
  • Module 2 - Quality
  • Module 3 - Efficacy
  • Module 4 - Safety
  • Module 5 - Biologicals
  • Module 6 - Pharmacovigilance
• Contact

Members login

Remember me next time

I agree to the privacy policy

• 
• 
• 

Guidelines

• Quality
  • Analytical validation
  • Impurities
  • Stability
  • Specifications
• Safety
  • Environmental safety
  • Metabolism and residue kinetics
  • Toxicology
  • Target animal safety
  • Antimicrobial safety
• Efficacy
  • Good clinical practice
  • Anthelmintics
  • Bioequivalence

Antimicrobial safety

• Pre-approval information for registration of new veterinary medicinal products for food producing animals with respect to antimicrobial resistance
  VICH GL27 (Antimicrobial resistance: pre-approval) - Implemented in December 2004
• Studies to evaluate the safety of residues of veterinary drugs in human food: General approach to establish a microbiological ADI
  VICH GL36(R)  (Safety) May 2004 - Implemented in June 2013
• Studies to evaluate the safety of residues of veterinary drugs in human food: General approach to establish a microbiological ADI
  VICH GL36(R2) (Safety: microbiological ADI) - February 2019 - Released for implementation at Step 7 in the regions by August 2019